Generate Chart For |
|
|
(Chart displayed below) |
Rat Strains
{{sample.term}}
|
Measurement Methods
{{method.term}}
|
|
|
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000363 | F344/NHsd | female | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 17 | mU/l | 2.4 | 7.5895 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11615 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 1.8 | (mg/dl) x min | 0.52 | 1.3758 | MMO:0000113 | oral glucose tolerance test | | 0 | trapezoid rule used for calculation | oral dose | | | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 11606 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000046 | blood glucose level | | | | 88.2 | mg/dl | 3.6 | 13.9427 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11454 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 86.4 | mg/dl | 3.6 | 11.9398 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11453 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 86.4 | mg/dl | 1.8 | 5.9699 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11452 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 20 | mU/l | 2.5 | 7.9057 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11614 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 8.3 | (mg/dl) x min | 1.91 | 4.2709 | MMO:0000113 | oral glucose tolerance test | | 0.0 | trapezoid rule used for calculation | oral dose | | | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 11604 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000363 | F344/NHsd | male | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 43 | mU/l | 4.6 | 14.5465 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11613 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 14072.727132 | (mg/dl) x min | 363.6364 | 1206.0454 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11469 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 311.4 | mg/dl | 10.8 | 35.8195 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11463 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 64.1 | mU/l | 9.7 | 30.6741 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11612 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 13599.999864 | (mg/dl) x min | 327.2727 | 1085.4408 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11468 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 309.6 | mg/dl | 9.0 | 29.8496 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11462 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 12818.18169 | (mg/dl) x min | 218.1818 | 845.0145 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11467 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000046 | blood glucose level | | | | 286.2 | mg/dl | 7.2 | 27.8855 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11461 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 18199.999818 | (mg/dl) x min | 509.0909 | 1688.4635 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11448 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 190.8 | mg/dl | 9.0 | 29.8496 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11460 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 17654.545278 | (mg/dl) x min | 636.3636 | 2110.5794 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11447 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 189 | mg/dl | 7.2 | 23.8797 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11459 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 15545.45439 | (mg/dl) x min | 381.8182 | 1478.7754 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11446 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000046 | blood glucose level | | | | 169.2 | mg/dl | 5.4 | 20.9141 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11458 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 99 | mg/dl | 3.6 | 11.9398 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11457 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 91.8 | mg/dl | 1.8 | 5.9699 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11456 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 88.2 | mg/dl | 1.8 | 5.9699 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11455 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000046 | blood glucose level | | | | 219.6 | mg/dl | 5.4 | 20.9141 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11437 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 153 | mg/dl | 5.4 | 17.9098 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11436 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 145.8 | mg/dl | 9.0 | 29.8496 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11435 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000046 | blood glucose level | | | | 135 | mg/dl | 5.4 | 20.9141 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11434 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 129.6 | mg/dl | 3.6 | 11.9398 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11433 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 127.8 | mg/dl | 3.6 | 11.9398 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11432 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000046 | blood glucose level | | | | 86.4 | mg/dl | 3.6 | 13.9427 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11451 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000046 | blood glucose level | | | | 86.4 | mg/dl | 1.8 | 6.9714 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11450 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000046 | blood glucose level | | | | 84.6 | mg/dl | 1.8 | 5.9699 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11449 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 333 | mg/dl | 14.4 | 47.7594 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11442 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 313.2 | mg/dl | 12.6 | 41.7895 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11441 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000046 | blood glucose level | | | | 271.8 | mg/dl | 9.0 | 34.8569 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11440 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 253.8 | mg/dl | 12.6 | 41.7895 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11439 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 252 | mg/dl | 7.2 | 23.8797 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11438 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000046 | blood glucose level | | | | 109.8 | mg/dl | 3.6 | 13.9427 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11431 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 104.4 | mg/dl | 3.6 | 11.9398 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11430 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000046 | blood glucose level | | | | 100.8 | mg/dl | 5.4 | 17.9098 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11429 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000046 | blood glucose level | | | | 91.8 | mg/dl | 1.8 | 6.9714 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11428 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.003596 | mg/dl | 0.001 | 0.0035 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67622 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.004466 | mg/dl | 4.0E-4 | 0.0016 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67623 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.007076 | mg/dl | 0.0013 | 0.0042 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67624 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.071572 | mg/dl | 0.0106 | 0.0409 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67625 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.031436 | mg/dl | 0.0044 | 0.0146 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67626 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.073254 | mg/dl | 0.0083 | 0.0275 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67627 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 65 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.028884 | mg/dl | 0.0039 | 0.0153 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67628 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.023084 | mg/dl | 0.0039 | 0.0131 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67629 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 65 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.05684 | mg/dl | 0.0089 | 0.0294 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67630 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.01305 | mg/dl | 0.0028 | 0.0092 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67631 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.01218 | mg/dl | 0.0016 | 0.0061 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67632 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.013804 | mg/dl | 0.0046 | 0.0154 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67633 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.08265 | mg/dl | 0.0119 | 0.046 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67634 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.04698 | mg/dl | 0.0112 | 0.0371 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67635 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.067628 | mg/dl | 0.0166 | 0.0552 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67636 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 15 | | CMO:0000358 | serum insulin level | | | | 0.0696 | mg/dl | 0.0108 | 0.0418 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67637 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.045936 | mg/dl | 0.011 | 0.0364 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67638 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000281 | F344.GK-(D1Mgh10-D1Rat119)/Swe | male | 95 days | 11 | | CMO:0000358 | serum insulin level | | | | 0.066178 | mg/dl | 0.0172 | 0.0571 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67640 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000046 | blood glucose level | | | | 90 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67647 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000046 | blood glucose level | | | | 334.8 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67648 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000046 | blood glucose level | | | | 248.4 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67649 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000046 | blood glucose level | | | | 118.8 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 60 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67650 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000046 | blood glucose level | | | | 111.6 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 90 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67651 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000358 | serum insulin level | | | | 0.003654 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 0 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67656 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000358 | serum insulin level | | | | 0.0116 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 15 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67657 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
85 | Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. | blood insulin amount | | RS:0000305 | F344/DuCrlCrlj | male | 95 days | 20 | | CMO:0000358 | serum insulin level | | | | 0.01247 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | | post glucose injection | 30 | min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67658 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) | |
312 | Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 149.2 | mg/dl | 3.0 | 11.225 | MMO:0000113 | oral glucose tolerance test | | | | glucose challenge | 0 | min | fasting (for 16 hours) then glucose solution | 12776 | fasting (for 16 hours) | glucose solution | |
312 | Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 344.3 | mg/dl | 8.5 | 31.8041 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | glucose challenge | 30 | min | fasting (for 16 hours) then glucose solution (for 0.5 hours) | 12777 | fasting (for 16 hours) | glucose solution (for 0.5 hours) | |
312 | Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 91.3 | mg/dl | 1.5 | 6.7082 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | glucose challenge | 0 | min | fasting (for 16 hours) then glucose solution | 12779 | fasting (for 16 hours) | glucose solution | |
312 | Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 124.8 | mg/dl | 2.3 | 10.2859 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | glucose challenge | 30 | min | fasting (for 16 hours) then glucose solution (for 0.5 hours) | 12783 | fasting (for 16 hours) | glucose solution (for 0.5 hours) | |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000976 | WBN/KobSlc | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 266.7 | mg/dl | 13.9 | 31.0813 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 30 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12892 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000976 | WBN/KobSlc | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 313.5 | mg/dl | 25.9 | 57.9142 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 60 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12895 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000976 | WBN/KobSlc | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 216.9 | mg/dl | 8.6 | 19.2302 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 120 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12896 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood insulin amount | | RS:0000976 | WBN/KobSlc | male | 120 days | 5 | | CMO:0000358 | serum insulin level | | serum glucose | | 0.000452 | mg/dl | 0.0 | 1.0E-4 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 30 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12904 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000133 | BN/CrlCrlj | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 178.1 | mg/dl | 7.9 | 17.6649 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 30 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12908 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000133 | BN/CrlCrlj | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 211.3 | mg/dl | 17.9 | 40.0256 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 60 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12909 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood glucose amount | WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus | RS:0000133 | BN/CrlCrlj | male | 120 days | 5 | | CMO:0000046 | blood glucose level | | serum glucose | | 154.7 | mg/dl | 13.8 | 30.8577 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 120 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12910 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
321 | Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. | blood insulin amount | | RS:0000133 | BN/CrlCrlj | male | 120 days | 5 | | CMO:0000358 | serum insulin level | | serum glucose | | 0.000195 | mg/dl | 1.0E-4 | 1.0E-4 | MMO:0000113 | oral glucose tolerance test | | | glucose dose not specified | glucose challenge | 30 | min | controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution | 12912 | controlled protein content diet (for 120 days) | fasting (for 9 hours) | glucose solution |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0000306 | F344/NCrl | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 180.8471924 | mU/l | 74.3208 | 257.4547 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13081 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0000306 | F344/NCrl | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 325.8 | mg/dl | 10.8 | 37.4123 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13086 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0000306 | F344/NCrl | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 246.6 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13087 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 136.254734 | mU/l | 14.8642 | 51.4909 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13089 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 367.2 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13091 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0000280 | F344.GK-(D1Arb42a-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 297 | mg/dl | 12.6 | 43.6477 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13092 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0001300 | F344.GK-(D1Rat175-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 131.3000164 | mU/l | 12.3868 | 42.9091 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13095 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001300 | F344.GK-(D1Rat175-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 396 | mg/dl | 10.8 | 37.4123 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13096 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001300 | F344.GK-(D1Rat175-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 336.6 | mg/dl | 10.8 | 37.4123 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13097 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0001290 | F344.GK-(D1Got250-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 185.80191 | mU/l | 19.8189 | 68.6546 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0 | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13100 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001290 | F344.GK-(D1Got250-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 369 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13101 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001290 | F344.GK-(D1Got250-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 279 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13103 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0001298 | F344.GK-(D1Mgh14-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 156.0736044 | mU/l | 22.2962 | 77.2364 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0 | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13105 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001298 | F344.GK-(D1Mgh14-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 333 | mg/dl | 14.4 | 49.8831 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13106 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001298 | F344.GK-(D1Mgh14-D1Rat90)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 250.2 | mg/dl | 10.8 | 37.4123 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13107 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0001301 | F344.GK-(D1Rat83-D1Rat376)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 178.3698336 | mU/l | 9.9094 | 34.3273 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0 | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13109 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001301 | F344.GK-(D1Rat83-D1Rat376)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 333 | mg/dl | 7.2 | 24.9415 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13110 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001301 | F344.GK-(D1Rat83-D1Rat376)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 243 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13111 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood insulin amount | | RS:0001302 | F344.GK-(D1Swe4-D1Rat85)/Swe | male | 95 days | 12 | | CMO:0000349 | blood insulin level | | micrograms/L | | 230.3943684 | mU/l | 24.7736 | 85.8182 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0 | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13113 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001302 | F344.GK-(D1Swe4-D1Rat85)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 306 | mg/dl | 9.0 | 31.1769 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 15 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13114 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
330 | Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. | blood glucose amount | | RS:0001302 | F344.GK-(D1Swe4-D1Rat85)/Swe | male | 95 days | 12 | | CMO:0000046 | blood glucose level | | | | 205.2 | mg/dl | 10.8 | 37.4123 | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | | | post glucose injection | 30 | min | fasting (for 6 hours) then glucose solution (2 g/kg) | 13115 | fasting (for 6 hours) | glucose solution (2 g/kg) | |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000046 | blood glucose level | | | | 99 | mg/dl | 4.48 | 11.853 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 0 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13156 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000046 | blood glucose level | | | | 134.1 | mg/dl | 4.7 | 12.435 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 15 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13157 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000046 | blood glucose level | | | | 149.1 | mg/dl | 4.2 | 11.1122 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 30 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13158 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000046 | blood glucose level | | | | 157 | mg/dl | 5.21 | 13.7844 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 60 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13159 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000364 | F344/NSlc | male | 420 days | 7 | | CMO:0000046 | blood glucose level | | | | 149 | mg/dl | 3.52 | 9.313 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 120 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13160 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000046 | blood glucose level | | | | 566.2 | mg/dl | 26.69 | 59.6807 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 0 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13162 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000046 | blood glucose level | | | | 705 | mg/dl | 46.77 | 104.5809 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 15 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13164 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000046 | blood glucose level | | | | 767.2 | mg/dl | 17.6 | 39.3548 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 30 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13166 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000046 | blood glucose level | | | | 702.8 | mg/dl | 25.39 | 56.7738 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 60 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13167 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
106 | Fuse M, et al., Physiol Genomics. 2008 Jul 8;. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 420 days | 5 | | CMO:0000046 | blood glucose level | | | | 640.6 | mg/dl | 16.99 | 37.9908 | MMO:0000113 | oral glucose tolerance test | | 0 | | oral dose | 120 | min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13168 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 173.8 | mg/dl | 5.5 | 17.3925 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13173 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 98.1 | mg/dl | 2.5 | 7.9057 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13174 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000363 | F344/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 131.6 | mg/dl | 3.0 | 9.4868 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13176 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000363 | F344/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 88 | mg/dl | 3.1 | 9.8031 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13177 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000363 | F344/NHsd | female | 105 days | 10 | | CMO:0000042 | plasma glucose level | | | | 121.7 | mg/dl | 5.1 | 16.1276 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | Post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13180 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000363 | F344/NHsd | female | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 65.1 | mg/dl | 3.6 | 11.3842 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13181 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 163.7 | mg/dl | 7.2 | 22.7684 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13183 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 84.3 | mg/dl | 6.9 | 21.8197 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13184 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
251 | Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. | blood glucose amount | | RS:0000065 | WOKW | female | 0 days | 12 | | CMO:0000046 | blood glucose level | | average of measures taken at 196 days, 210 days and 224 days | | 91 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | glucose analyser (Medingen ESAT 6660-2, Germany) | intraperitoneal injection | 0 | min | glucose solution (2 g/kg) | 13271 | glucose solution (2 g/kg) | | |
251 | Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. | blood glucose amount | | RS:0000065 | WOKW | female | 0 days | 12 | | CMO:0000350 | blood glucose level area under curve (AUC) | | samples taken at 0, 10, 30, 60 minutes | | 11127.272616 | (mg/dl) x min | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | glucose analyser (Medingen ESAT 6660-2, Germany) | intraperitoneal injection | 60 | min | glucose solution (2 g/kg) | 13272 | glucose solution (2 g/kg) | | |
251 | Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. | blood glucose amount | | RS:0000243 | DA/K | female | 0 days | 12 | | CMO:0000046 | blood glucose level | | average of measures taken at 196 days, 210 days and 224 days | | 105 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | glucose analyser (Medingen ESAT 6660-2, Germany) | intraperitoneal injection | 0 | min | glucose solution (2 g/kg) | 13273 | glucose solution (2 g/kg) | | |
251 | Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. | blood glucose amount | | RS:0000243 | DA/K | female | 0 days | 12 | | CMO:0000350 | blood glucose level area under curve (AUC) | | samples taken at 0, 10, 30, 60 minutes | | 8636.36355 | (mg/dl) x min | | | MMO:0000164 | intraperitoneal glucose tolerance test | tail vein | 0.0 | glucose analyser (Medingen ESAT 6660-2, Germany) | intraperitoneal injection | 60 | min | glucose solution (2 g/kg) | 13274 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0002074 | N:HS | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 111.6 | mg/dl | 0.4854 | 7.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 0 | min | glucose solution (2 g/kg) | 65944 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000154 | BN/SsN | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 108.54 | mg/dl | 1.0194 | 15.12 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 0 | min | glucose solution (2 g/kg) | 65945 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000714 | WKY/N | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 138.24 | mg/dl | 0.7888 | 11.7 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 0 | min | glucose solution (2 g/kg) | 65946 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000166 | BUF/N | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 166.14 | mg/dl | | | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 0 | min | glucose solution (2 g/kg) | 65947 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000313 | F344/NRrrc | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 123.12 | mg/dl | 0.8131 | 12.06 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 0 | min | glucose solution (2 g/kg) | 65948 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0002074 | N:HS | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 151.2 | mg/dl | 2.3058 | 34.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 30 | min | glucose solution (2 g/kg) | 65972 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000154 | BN/SsN | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 156.42 | mg/dl | 3.4829 | 51.66 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 30 | min | glucose solution (2 g/kg) | 65975 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000714 | WKY/N | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 406.8 | mg/dl | 4.6722 | 69.3 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 30 | min | glucose solution (2 g/kg) | 65976 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000313 | F344/NRrrc | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 249.12 | mg/dl | 5.1576 | 76.5 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 30 | min | glucose solution (2 g/kg) | 65977 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0002074 | N:HS | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 124.2 | mg/dl | 0.9708 | 14.4 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | glucose injection | 60 | min | glucose solution (2 g/kg) | 65978 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0002074 | N:HS | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 109.8 | mg/dl | 0.0728 | 1.08 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 120 | min | glucose solution (2 g/kg) | 65979 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000154 | BN/SsN | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 116.64 | mg/dl | 1.5048 | 22.32 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 120 | min | glucose solution (2 g/kg) | 65981 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000714 | WKY/N | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 221.4 | mg/dl | 3.3737 | 50.04 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 120 | min | glucose solution (2 g/kg) | 65982 | glucose solution (2 g/kg) | | |
114 | Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 | blood glucose amount | | RS:0000313 | F344/NRrrc | both | 125 days to 118 days | 220 | | CMO:0000046 | blood glucose level | | | | 158.4 | mg/dl | 1.0922 | 16.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | glucose injection | 120 | min | glucose solution (2 g/kg) | 65983 | glucose solution (2 g/kg) | | |
729 | Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 289 | mg/dl | 8.5524 | 32.0 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral dose | 120 | min | fasting (for 16 hours) then glucose solution | 67277 | fasting (for 16 hours) | glucose solution | |
729 | Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. | blood glucose amount | | RS:0001349 | LETO | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 150 | mg/dl | 1.8708 | 7.0 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral dose | 120 | min | fasting (for 16 hours) then glucose solution | 67278 | fasting (for 16 hours) | glucose solution | |
729 | Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. | blood glucose amount | | RS:0000305 | F344/DuCrlCrlj | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 128 | mg/dl | 2.2678 | 6.0 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral dose | 120 | min | fasting (for 16 hours) then glucose solution | 67279 | fasting (for 16 hours) | glucose solution | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 124.8 | mg/dl | 2.3 | 10.2859 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 30 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68072 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000313 | F344/NRrrc | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 124.1 | mg/dl | 1.6 | 4.2332 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 30 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68073 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 344.3 | mg/dl | 8.5 | 31.8041 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 30 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68074 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 129.8 | mg/dl | 1.7 | 7.6026 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68075 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000313 | F344/NRrrc | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 185.5 | mg/dl | 4.0 | 10.583 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68076 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 352.8 | mg/dl | 8.6 | 32.1783 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68077 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 138.7 | mg/dl | 2.6 | 11.6276 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 90 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68078 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000313 | F344/NRrrc | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 139 | mg/dl | 2.4 | 6.3498 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 90 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68079 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 402.4 | mg/dl | 19.0 | 71.0915 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 90 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68080 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 120.5 | mg/dl | 2.6 | 11.6276 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 120 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68081 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000313 | F344/NRrrc | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 128 | mg/dl | 2.4 | 6.3498 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 120 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68082 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 289.9 | mg/dl | 8.7 | 32.5524 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 120 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68083 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000113 | BN | male | 210 days | 20 | | CMO:0000042 | plasma glucose level | | | | 91.3 | mg/dl | 1.5 | 6.7082 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 0 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68069 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000313 | F344/NRrrc | male | 210 days | 7 | | CMO:0000042 | plasma glucose level | | | | 104 | mg/dl | 6.1 | 16.1391 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 0 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68070 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
836 | Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 | blood glucose amount | | RS:0000284 | OLETF | male | 210 days | 14 | | CMO:0000042 | plasma glucose level | | | | 149.2 | mg/dl | 3.0 | 11.225 | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral glucose | 0 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 68071 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
833 | Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206. | blood glucose amount | | RS:0000430 | BN/Seac | male | 140 days | N/A | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 17646 | (mg/dl) x min | 510.0 | | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral dose | 120 | min | fasting (for 18 hours) then glucose solution (2 g/kg) | 67911 | fasting (for 18 hours) | glucose solution (2 g/kg) | |
833 | Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206. | blood glucose amount | | RS:0000709 | SDT/Jcl | male | 140 days | N/A | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 37998 | (mg/dl) x min | 1584.0 | | MMO:0000113 | oral glucose tolerance test | | 0.0 | | oral dose | 120 | min | fasting (for 18 hours) then glucose solution (2 g/kg) | 67912 | fasting (for 18 hours) | glucose solution (2 g/kg) | |
1123 | Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. | blood glucose amount | | RS:0001087 | WOKW/K | not specified | 224 days to 196 days | 12 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 11854.545336 | (mg/dl) x min | 456.6316 | 1581.8182 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | IPGTT | 60 | min | glucose solution (2 g/kg) | 96850 | glucose solution (2 g/kg) | | |
1123 | Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. | blood glucose amount | | RS:0000243 | DA/K | not specified | 224 days to 196 days | 12 | | CMO:0000350 | blood glucose level area under curve (AUC) | | | | 8872.727184 | (mg/dl) x min | 335.9129 | 1163.6364 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | IPGTT | 60 | min | glucose solution (2 g/kg) | 96851 | glucose solution (2 g/kg) | | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 61 days | 6 | | CMO:0000046 | blood glucose level | | | | 144 | mg/dl | 7.2 | 17.6363 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106911 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 243 days | 11 | | CMO:0000046 | blood glucose level | | | | 172.8 | mg/dl | 10.8 | 35.8195 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106912 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 426 days | 11 | | CMO:0000046 | blood glucose level | | | | 228.6 | mg/dl | 9.0 | 29.8496 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106913 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 61 days | 6 | | CMO:0000046 | blood glucose level | | | | 84.6 | mg/dl | 5.4 | 13.2272 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106914 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 243 days | 9 | | CMO:0000046 | blood glucose level | | | | 84.6 | mg/dl | 1.8 | 5.4 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106915 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 426 days | 9 | | CMO:0000046 | blood glucose level | | | | 138.6 | mg/dl | 5.4 | 16.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | fasting (for 6 hours) then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106916 | fasting (for 6 hours) | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 61 days | 6 | | CMO:0000046 | blood glucose level | | | | 268.2 | mg/dl | 14.4 | 35.2727 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | tail vein blood | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106905 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 243 days | 11 | | CMO:0000046 | blood glucose level | | | | 311.4 | mg/dl | 14.4 | 47.7594 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106906 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001317 | GK/MolTac | female | 426 days | 11 | | CMO:0000046 | blood glucose level | | | | 289.8 | mg/dl | 10.8 | 35.8195 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106907 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 61 days | 6 | | CMO:0000046 | blood glucose level | | | | 106.2 | mg/dl | 7.2 | 17.6363 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106908 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 243 days | 9 | | CMO:0000046 | blood glucose level | | | | 88.2 | mg/dl | 5.4 | 16.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106909 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3071 | Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. | blood glucose amount | fasting blood glucose, non fasting blood glucose | RS:0001602 | WKY/NMolTac | female | 426 days | 9 | | CMO:0000046 | blood glucose level | | | | 93.6 | mg/dl | 5.4 | 16.2 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0.0 | | | | | control condition then glucose solution (2 g/kg) (between 0 and 2.5 hours) | 106910 | control condition | glucose solution (2 g/kg) (between 0 and 2.5 hours) | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | male | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 26.4 | uU/islet/90min | 3.7 | 21.2549 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | glucose solution (2.8 mmol/l) (for 1.5 hours) | 110627 | glucose solution (2.8 mmol/l) (for 1.5 hours) | | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | male | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 18.3 | uU/islet/90min | 1.9 | 10.9147 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) then glucose solution (2.8 mmol/l) (for 1.5 hours) | 110628 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | glucose solution (2.8 mmol/l) (for 1.5 hours) | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | female | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 33 | uU/islet/90min | 4.6 | 26.425 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | glucose solution (2.8 mmol/l) (for 1.5 hours) | 110629 | glucose solution (2.8 mmol/l) (for 1.5 hours) | | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | female | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 12.9 | uU/islet/90min | 2.6 | 14.9359 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) then glucose solution (2.8 mmol/l) (for 1.5 hours) | 110630 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | glucose solution (2.8 mmol/l) (for 1.5 hours) | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | male | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 113.4 | uU/islet/90min | 11.1 | 63.7646 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | glucose solution (16.7 mmol/l) (for 1.5 hours) | 110631 | glucose solution (16.7 mmol/l) (for 1.5 hours) | | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | male | 73 days | 32 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 113.3 | uU/islet/90min | 7.5 | 42.4264 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) then glucose solution (16.7 mmol/l) (for 1.5 hours) | 110632 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | glucose solution (16.7 mmol/l) (for 1.5 hours) | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | female | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 124 | uU/islet/90min | 6.0 | 34.4674 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | glucose solution (16.7 mmol/l) (for 1.5 hours) | 110633 | glucose solution (16.7 mmol/l) (for 1.5 hours) | | |
3179 | Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. | pancreatic beta cell physiology trait | | RS:0001299 | GK | female | 73 days | 33 | | CMO:0001216 | pancreatic islet insulin release measurement | | | | 83.5 | uU/islet/90min | 5.4 | 31.0206 | MMO:0000073 | radioimmunoassay | | 0.0 | ex vivo incubation | glucose | 90 | min | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) then glucose solution (16.7 mmol/l) (for 1.5 hours) | 110634 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | glucose solution (16.7 mmol/l) (for 1.5 hours) | |
3167 | Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. | blood insulin amount | | RS:0004409 | Jcl:WI | male | 140 days | 7 | | CMO:0000358 | serum insulin level | | | | 0.00033 | mg/dl | 0.0 | 1.0E-4 | MMO:0000075 | enzyme linked immunosorbent assay | | 0.0 | | glucose | 30 | min | fasting then glucose solution (2 g/kg) (for 0.5 hours) | 110217 | fasting | glucose solution (2 g/kg) (for 0.5 hours) | |
3167 | Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. | blood insulin amount | | RS:0004409 | Jcl:WI | male | 140 days | 7 | | CMO:0000358 | serum insulin level | | | | 0.00034 | mg/dl | 0.0 | 1.0E-4 | MMO:0000075 | enzyme linked immunosorbent assay | | 0.0 | | glucose | 30 | min | vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) | 110218 | vildagliptin (30 mg/kg/d) (for 92 days) | fasting | glucose solution (2 g/kg) (for 0.5 hours) |
3167 | Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. | blood insulin amount | | RS:0004580 | GK/Jcl | male | 140 days | 7 | | CMO:0000358 | serum insulin level | | | | 0.00018 | mg/dl | 0.0 | 1.0E-4 | MMO:0000075 | enzyme linked immunosorbent assay | | 0.0 | | glucose | 30 | min | fasting then glucose solution (2 g/kg) (for 0.5 hours) | 110219 | fasting | glucose solution (2 g/kg) (for 0.5 hours) | |
3167 | Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. | blood insulin amount | | RS:0004409 | Jcl:WI | male | 140 days | 7 | | CMO:0000358 | serum insulin level | | | | 0.00027 | mg/dl | 1.0E-4 | 2.0E-4 | MMO:0000075 | enzyme linked immunosorbent assay | | 0.0 | | glucose | 30 | min | vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) | 110220 | vildagliptin (30 mg/kg/d) (for 92 days) | fasting | glucose solution (2 g/kg) (for 0.5 hours) |